⏳ Fetching live dividend data...
Home › Calculator › RSPI Dividend Calculator 2026
RespireRx Pharmaceuticals Inc. · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in RSPI → $2.8938885275744073e+28M in 10 years · $2,409,405,308,201,291,200,000,000,000,000,000.00/month
RespireRx Pharmaceuticals Inc. is dedicated to researching, developing, and commercializing pharmaceutical products aimed at addressing neurological and psychiatric conditions. The company operates through two primary therapeutic platforms: ResolutionRx, which investigates pharmaceutical cannabinoids, and EndeavourRx, focused on neuromodulators. The ResolutionRx platform encompasses cannabinoids such as dronabinol, a compound that interacts with CB1 and CB2 endocannabinoid receptors. This agent is being explored for its potential in mitigating chemotherapy-induced nausea and vomiting, alleviating anorexia in AIDS patients, and treating obstructive sleep apnea. Their EndeavourRx neuromodulator platform includes two distinct programs: AMPAkines and GABAkines. The AMPAkines program features proprietary compounds acting as positive allosteric modulators (PAMs) of AMPA-type glutamate receptors, designed to enhance neuronal function. Concurrently, the GABAkines program involves their own PAMs for GABAA receptors. A key candidate, CX1739, an ampakine, has successfully completed Phase II clinical trials for both opioid-induced respiratory depression and central sleep apnea. Additionally, RespireRx is advancing CX717, CX1739, and CX1942, which demonstrate potential clinical applications in various areas, including neurobehavioral and cognitive disorders rooted in the central nervous system, spinal cord injuries, specific neurological illnesses, and multiple rare indications. The company, initially known as Cortex Pharmaceuticals, Inc., rebranded to RespireRx Pharmaceuticals Inc. in December 2015. Established in 1987, RespireRx Pharmaceuticals Inc. maintains its corporate headquarters in Glen Rock, New Jersey.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RSPI position with:
Real after-tax yield depends on where you live and how you hold RSPI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 111111.11% | 111108.31% | $11,111,111 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 94444.44% | 94441.64% | $9,444,444 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 88888.89% | 88886.09% | $8,888,889 / yr |
| 🇬🇧 UK ISA | 0% | 111111.11% | 111108.31% | $11,111,111 / yr |
| 🇬🇧 UK Taxable | 8.75% | 101388.89% | 101386.09% | $10,138,889 / yr |
| 🇨🇦 TFSA | 0% | 111111.11% | 111108.31% | $11,111,111 / yr |
| 🇨🇦 CA Taxable | 25% | 83333.33% | 83330.53% | $8,333,333 / yr |
| 🇦🇺 Super (pension) | 15% | 94444.44% | 94441.64% | $9,444,444 / yr |
| 🇦🇺 AU Taxable | 30% | 77777.78% | 77774.98% | $7,777,778 / yr |
| 🇩🇪 DE Taxable | 26.375% | 81805.55% | 81802.75% | $8,180,555 / yr |
| 🇫🇷 FR Taxable | 30% | 77777.78% | 77774.98% | $7,777,778 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
RSPI pays quarterly — 4 times per year. Next ex-div: TBD.
How RSPI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RSPI sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2020-09-30 | 2,000,000 | $0.01 | $10.8K | ||
| C-Conversion | 2020-09-30 | 4,409,063 | — | — | ||
| C-Conversion | 2020-09-30 | 4,409,063 | $0.01 | $30.9K | ||
| C-Conversion | 2020-09-30 | 4,409,063 | $0.01 | $30.9K | ||
| C-Conversion | 2020-09-30 | 4,409,063 | — | — | ||
| J-Other | 2020-09-30 | 28.218 | $0.01 | — | ||
| J-Other | 2020-09-30 | 28.218 | $0.01 | — | ||
| C-Conversion | 2020-09-30 | 28.218 | $0.01 | — | ||
| C-Conversion | 2020-09-30 | 28.218 | $0.01 | — | ||
| A-Award | 2020-09-30 | 5,000,000 | $0.01 | $27.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RSPI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
RespireRx Pharmaceuticals Inc. (RSPI) is currently trading at $0.00, 96% below its 52-week high. The current dividend yield is 111111.11% based on an annual payout of $2.00 per share.
RespireRx Pharmaceuticals Inc. (RSPI) is a healthcare stock currently trading at $0.00 with a dividend yield of 111111.11%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever